Your session is about to expire
← Back to Search
High Intensity Circuit Training vs Traditional Exercise for Type 2 Diabetes
N/A
Recruiting
Research Sponsored by Kennesaw State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Non-insulin dependent
No medicinal treatment
Must not have
Those who have undergone any revascularization procedure
Diagnosed with or symptomatic of any renal, pulmonary, or cardiovascular disease (CVD)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre and post 16-week intervention
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare the effects of two exercise interventions on people with type-2 diabetes - a high intensity body-weight circuit (HIBC) and a traditional exercise intervention (TEI).
Who is the study for?
This trial is for middle-aged individuals recently diagnosed with type-2 diabetes who haven't started any medicinal treatment and are not insulin-dependent. They should have an HbA1c level between 6% and 8%, no current exercise program, and must be willing to be randomly assigned to a workout group. Smokers or those with kidney, lung, heart diseases, past revascularization procedures, or cognitive dysfunction cannot participate.
What is being tested?
The study is testing the effectiveness of a new high intensity body-weight circuit (HIBC) training compared to traditional exercise interventions (TEI). It aims to see which one better improves metabolic profile, body composition, and fitness in people with type-2 diabetes.
What are the potential side effects?
While specific side effects aren't listed for these physical activities, participants may experience general exercise-related issues like muscle soreness, fatigue or injury. The intensity of the workouts could also pose risks for those unaccustomed to vigorous activity.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I do not need insulin for my diabetes.
Select...
I am not taking any medication.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had a procedure to improve blood flow to my heart.
Select...
I have been diagnosed with or show symptoms of kidney, lung, or heart disease.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre and post 16-week intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre and post 16-week intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Body Composition change within participant
Oxygen
HbA1c change within participant
+1 moreSecondary study objectives
Compare measures 1 through 4 between the HIBC to TEI interventions
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: high intensity body-weight circuit (HIBC)Experimental Treatment1 Intervention
HIBC Exercise Protocol- circuit repetition and order is as follows: modified squats (10 repetitions), modified rows (5 repetitions), crunches (10), and modified push-ups (5). The exercise sessions will involve repeating a series of repetitions of each movement in sequence, and completing as many sequences as possible in good form in the time allotted for the exercise (initially, 5 minutes). Three sessions per week will be completed at home. After three weeks of training, participants will be asked to add a fourth session each week. Initially, the HIBC sessions will be five minutes long, and the duration of the sessions will increase by one minute each week as tolerated beginning in week four, peaking at 10-minutes per session (warm up not included in this timing) as early as the eighth week of training. Session duration will be capped at 10-minutes.
Find a Location
Who is running the clinical trial?
Kennesaw State UniversityLead Sponsor
13 Previous Clinical Trials
816 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are currently smoking cigarettes.I have had a procedure to improve blood flow to my heart.You have been diagnosed with problems related to thinking and memory.I was diagnosed with type 2 diabetes within the last year.I have been diagnosed with or show symptoms of kidney, lung, or heart disease.I do not need insulin for my diabetes.Your HbA1c level is between 6% and 8%.I am not taking any medication.I am willing to be assigned to any treatment group by chance.
Research Study Groups:
This trial has the following groups:- Group 1: high intensity body-weight circuit (HIBC)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger